As of 2024-12-12, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 239.53 USD. This relative valuation is based on P/E multiples. With the latest stock price at 193.55 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is 23.8%.
The range of the Relative Valuation is 219.85 - 274.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 32.5x | 29.4x |
| Forward P/E multiples | 21.9x - 27.4x | 24.2x |
| Fair Price | 219.85 - 274.56 | 239.53 |
| Upside | 13.6% - 41.9% | 23.8% |
| Date | P/E |
| 2024-12-11 | 23.96 |
| 2024-12-10 | 24.40 |
| 2024-12-09 | 24.98 |
| 2024-12-06 | 23.75 |
| 2024-12-05 | 23.71 |
| 2024-12-04 | 24.68 |
| 2024-12-03 | 24.67 |
| 2024-12-02 | 24.92 |
| 2024-11-29 | 24.64 |
| 2024-11-27 | 24.71 |
| 2024-11-26 | 24.48 |
| 2024-11-25 | 24.92 |
| 2024-11-22 | 24.24 |
| 2024-11-21 | 24.04 |
| 2024-11-20 | 23.26 |
| 2024-11-19 | 23.04 |
| 2024-11-18 | 23.21 |
| 2024-11-15 | 23.24 |
| 2024-11-14 | 24.38 |
| 2024-11-13 | 25.57 |
| 2024-11-12 | 26.73 |
| 2024-11-11 | 27.32 |
| 2024-11-08 | 26.67 |
| 2024-11-07 | 26.03 |
| 2024-11-06 | 26.52 |
| 2024-11-05 | 23.36 |
| 2024-11-04 | 22.59 |
| 2024-11-01 | 22.40 |
| 2024-10-31 | 22.11 |
| 2024-10-30 | 22.46 |
| 2024-10-29 | 22.78 |
| 2024-10-28 | 23.09 |
| 2024-10-25 | 22.55 |
| 2024-10-24 | 22.62 |
| 2024-10-23 | 23.11 |
| 2024-10-22 | 23.02 |
| 2024-10-21 | 24.15 |
| 2024-10-18 | 24.48 |
| 2024-10-17 | 24.49 |
| 2024-10-16 | 24.15 |
| 2024-10-15 | 24.00 |
| 2024-10-14 | 23.91 |
| 2024-10-11 | 23.89 |
| 2024-10-10 | 23.70 |
| 2024-10-09 | 23.24 |
| 2024-10-08 | 23.13 |
| 2024-10-07 | 23.43 |
| 2024-10-04 | 23.61 |
| 2024-10-03 | 23.47 |
| 2024-10-02 | 23.88 |